A 68-year-old female patient with poorly controlled diabetes, hypertension, and osteoarthritis presents with mild confusion and dizziness. Recent diagnostics indicate moderate cerebral atrophy, elevated CRP levels, and a slight decline in renal function. Which nursing intervention should be prioritized to address the patient's current condition?

B) Collaborate with the healthcare provider to adjust the patient's antihypertensive and antidiabetic medications.

A) Initiate a new exercise program to improve mobility and reduce dizziness.

B) Collaborate with the healthcare provider to adjust the patient's antihypertensive and antidiabetic medications.

C) Increase dietary protein intake to support muscle strength and cognitive function.

D) Educate the patient about the importance of daily foot care to prevent diabetic complications.

A 68-year-old female patient with poorly controlled diabetes, osteoarthritis, and hypertension presents with mild confusion and dizziness. Recent diagnostics reveal a fasting blood sugar of 180 mg/dL, HbA1c of 8.2%, moderate cerebral atrophy, elevated CRP levels, and a creatinine level of 1.4 mg/dL. Which nursing intervention should be prioritized to address her interconnected health issues and prevent further decline?

A) Initiate a diabetic diet plan and encourage regular physical activity to improve glucose control.

B) Collaborate with the healthcare team to adjust her antihypertensive medications to better manage her blood pressure.

C) Educate the patient on cognitive exercises to slow the progression of neurodegenerative changes.

D) Coordinate a pain management plan that includes both pharmacological and non-pharmacological strategies.

A 68-year-old female patient with poorly controlled diabetes and osteoarthritis is being managed with a new treatment plan including an SGLT2 inhibitor and a topical NSAID. Which nursing intervention is most important to prioritize to assess the effectiveness of this revised care plan?

A) Monitor the patient's blood glucose levels regularly.

B) Evaluate the patient's joint range of motion daily.

C) Assess the patient's renal function through laboratory tests.

D) Observe for signs of cognitive improvement or decline.

A patient with poorly controlled diabetes and osteoarthritis is being considered for a new treatment regimen including an SGLT2 inhibitor and a topical NSAID. Which nursing intervention is most important to prioritize in the initial phase of this treatment plan?

B) Monitoring the patient’s blood glucose and renal function closely.

A) Educating the patient on the importance of adherence to the SGLT2 inhibitor.

B) Monitoring the patient’s blood glucose and renal function closely.

C) Encouraging increased physical activity to improve mobility.

D) Ensuring the patient understands how to apply the topical NSAID correctly.

A 65-year-old patient with type 2 diabetes mellitus and chronic kidney disease presents with improved blood glucose levels but reports dizziness when standing. Her blood pressure drops from 130/80 mmHg supine to 100/70 mmHg upon standing. Which nursing intervention is most appropriate to address her orthostatic hypotension while maintaining her current therapeutic regimen?

C) Advise the patient to rise slowly from a sitting or lying position.

A) Discontinue the SGLT2 inhibitor to prevent further renal stress.

B) Encourage the patient to increase fluid intake to manage dizziness.

C) Advise the patient to rise slowly from a sitting or lying position.

D) Increase the dosage of her antihypertensive medication to stabilize blood pressure.

A patient with type 2 diabetes and chronic kidney disease returns for a follow-up appointment. Her blood glucose levels have improved, but she reports episodes of dizziness when standing. Her blood pressure drops significantly from supine to standing positions. Which of the following interventions should the nurse prioritize to address her dizziness and prevent orthostatic hypotension?

A) Increase her fluid intake to improve blood volume.

B) Initiate a high-sodium diet to raise blood pressure.

C) Advise her to stand up quickly to reduce dizziness.

D) Discontinue the SGLT2 inhibitor to prevent further renal stress.

A patient with Type 2 Diabetes Mellitus is experiencing orthostatic hypotension and progressive renal impairment. After adjusting her fluid and dietary intake, her dizziness episodes have reduced, and her blood pressure has stabilized to some extent. However, her urine albumin-to-creatinine ratio and serum creatinine levels have increased. Which nursing intervention should be prioritized to address both her glycemic control and renal function?

B) Collaborate with the healthcare team to adjust the dosage of the SGLT2 inhibitor and consult nephrology for further evaluation.

A) Discontinue the SGLT2 inhibitor immediately and start insulin therapy.

B) Collaborate with the healthcare team to adjust the dosage of the SGLT2 inhibitor and consult nephrology for further evaluation.

C) Increase her fluid intake to improve renal clearance while continuing the current medication regimen.

D) Maintain the current treatment plan and monitor renal function monthly.

A 65-year-old female patient with type 2 diabetes and recent orthostatic hypotension adjustments reports a reduction in dizziness and stabilized blood pressure. However, she now shows signs of progressive renal impairment, with an increased urine albumin-to-creatinine ratio and elevated serum creatinine. Which nursing intervention is most appropriate to address her current condition while considering her diabetic management and renal health?

B) Collaborate with the healthcare provider to reduce the dose of the SGLT2 inhibitor and initiate a nephrology consult.

A) Discontinue the SGLT2 inhibitor immediately and switch to insulin therapy.

B) Collaborate with the healthcare provider to reduce the dose of the SGLT2 inhibitor and initiate a nephrology consult.

C) Increase the patient's fluid intake to promote renal perfusion and decrease the risk of dehydration.

D) Encourage the patient to continue her current medication regimen and monitor renal function monthly.

A patient with early chronic kidney disease has been transitioned to a GLP-1 receptor agonist and an ACE inhibitor. The nurse observes that the patient's blood pressure readings are occasionally 130/85 mmHg. Which nursing intervention is most appropriate to address the variability in the patient's blood pressure while maintaining renal protection?

B) Educate the patient on the importance of dietary sodium restriction to manage blood pressure.

A) Increase the dose of the ACE inhibitor to stabilize blood pressure.

B) Educate the patient on the importance of dietary sodium restriction to manage blood pressure.

C) Discontinue the GLP-1 receptor agonist and restart the SGLT2 inhibitor for better blood pressure control.

D) Encourage the patient to self-monitor blood pressure at home and report significant changes.

A patient with early chronic kidney disease has had her SGLT2 inhibitor discontinued and transitioned to a GLP-1 receptor agonist. Her antihypertensive therapy has also been modified to include an ACE inhibitor. Given these changes, which nursing intervention is most appropriate to monitor for potential complications related to the new medication regimen?

B) Assess the patient for signs of angioedema, such as facial swelling or difficulty breathing.

A) Monitor the patient's blood glucose levels closely for signs of hypoglycemia.

B) Assess the patient for signs of angioedema, such as facial swelling or difficulty breathing.

C) Check the patient’s urine output and monitor for signs of hyperkalemia.

D) Evaluate the patient’s weight daily to assess for fluid retention.

long-term care patient in need of assistance with mobility and activities of daily living - Nursing Case Study

Pathophysiology

• Primary mechanism: Neurodegeneration - Progressive loss of neurons and synapses, often seen in conditions like Parkinson’s or Alzheimer's, leads to impaired motor function and cognitive decline, affecting mobility and daily activities.

• Secondary mechanism: Muscle atrophy - Prolonged immobility or neurological impairment causes muscle wasting, reducing strength and endurance, further complicating movement and self-care.

• Key complication: Joint contractures - Limited mobility and muscle weakness can lead to joint stiffness and reduced range of motion, exacerbating difficulties in performing activities of daily living.

Patient Profile

Demographics:

78-year-old female, retired school teacher

History:

• Key past medical history: Osteoarthritis, Type 2 Diabetes, Hypertension

• Current medications: Metformin 500 mg BID, Lisinopril 10 mg QD, Acetaminophen 500 mg PRN for pain

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased difficulty with mobility and performing daily activities

• Key symptoms: Joint stiffness, occasional dizziness, mild confusion, swelling in lower extremities

• Vital signs: Blood pressure 160/95 mmHg, Heart rate 92 bpm, Respiratory rate 22 breaths per minute, Temperature 99.1°F, Oxygen saturation 94% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, a comprehensive series of diagnostic tests were performed to better understand the patient's condition and guide further management. Notably, the patient's blood glucose levels were found to be poorly controlled, with a fasting blood sugar of 180 mg/dL and an HbA1c of 8.2%. This indicates that her diabetes management may require adjustment, potentially impacting her overall health and mobility. Additionally, imaging studies, including a CT scan of the brain, revealed moderate cerebral atrophy consistent with neurodegenerative changes, potentially contributing to her mild confusion and dizziness.

Further laboratory tests showed elevated inflammatory markers, with a C-reactive protein (CRP) of 15 mg/L, suggestive of an inflammatory process, possibly due to her osteoarthritis. The patient's renal function was also assessed, revealing a slight decline with a creatinine level of 1.4 mg/dL, possibly influenced by her current management of hypertension and diabetes. These results highlight the need for a multidisciplinary approach to address the interconnected issues of her chronic conditions, mobility challenges, and potential cognitive decline.

These diagnostic findings underscore the importance of re-evaluating her treatment regimen and considering adjustments to her diabetes management, possibly integrating newer antidiabetic medications with a better cardiovascular and renal profile. The data provided also prompts a review of her pain management strategy, ensuring that her osteoarthritis is adequately controlled without exacerbating her renal function. This stage of the case study sets the stage for collaborative care planning, emphasizing the need for regular monitoring of her cognitive and physical status to prevent further deterioration and improve her quality of life.

Section 2

Following the new diagnostic results, the healthcare team met to address the interconnected health issues affecting the patient's mobility and overall well-being. The primary concern was her poorly controlled diabetes, which not only impacts her risk of vascular complications but also contributes to her current cognitive and mobility challenges. The team discussed adjusting her diabetes management plan, considering the introduction of a sodium-glucose cotransporter-2 (SGLT2) inhibitor, which has shown benefits in cardiovascular and renal outcomes. This change aims to improve her glycemic control while potentially slowing the progression of renal impairment observed in her recent labs.

In parallel, the team reviewed her pain management strategy for osteoarthritis, given the elevated inflammatory markers. The goal was to optimize her pain relief while minimizing renal strain. A trial of a topical non-steroidal anti-inflammatory drug (NSAID) was initiated to manage her joint pain locally with less systemic impact. This approach was chosen to potentially reduce the need for oral NSAIDs, which could exacerbate her renal function. The team also considered physical therapy to enhance her mobility, focusing on gentle exercises that could improve joint function without overexertion.

As part of the multidisciplinary care plan, regular monitoring of her cognitive status and renal function was emphasized. The patient was scheduled for follow-up blood tests to assess the impact of these interventions on her blood glucose levels and renal markers. Additionally, her cognitive function and dizziness would be closely monitored by the nursing staff, looking for any signs of improvement or further decline. This comprehensive approach aimed to stabilize her condition, improve her quality of life, and prevent further complications, setting the stage for evaluating her response to the new treatment regimen in the coming weeks.

Section 3

Following the implementation of the adjusted care plan, the patient returned for a follow-up appointment two weeks later, and her initial assessment revealed some promising changes alongside new challenges. Her blood glucose levels showed improvement, with her fasting blood sugar averaging around 140 mg/dL, down from 180 mg/dL. This reduction suggests that the introduction of the SGLT2 inhibitor is positively affecting her glycemic control. However, her renal function tests presented mixed results. Her estimated glomerular filtration rate (eGFR) remained stable at 50 mL/min/1.73 m², yet her urine albumin-to-creatinine ratio slightly increased to 350 mg/g, indicating ongoing renal stress and the need for careful monitoring.

Simultaneously, her cognitive status appeared stable, with no significant decline noted. However, she reported episodes of dizziness, particularly when standing, which could potentially be attributed to orthostatic hypotension. Her blood pressure readings varied, with a noted drop from 130/80 mmHg supine to 100/70 mmHg upon standing. This raised concerns about the balance between effective diabetic and cardiovascular management and maintaining adequate blood pressure levels.

In terms of mobility and pain management, the patient reported a slight improvement in joint pain, which she attributed to the topical NSAID application. Yet, her physical therapy sessions revealed continued difficulty with balance and coordination, exacerbated by the dizziness. The healthcare team decided to adjust her fluid and dietary intake to address potential volume depletion contributing to her orthostatic symptoms. This careful titration of interventions reflects the interconnected nature of her health issues and underscores the importance of ongoing assessment and clinical reasoning to adapt the care plan effectively.

Section 4

The focus on the patient's response to interventions reveals mixed outcomes, highlighting the complexity of her care needs. Two weeks after the adjustments in her fluid and dietary intake, aimed at mitigating orthostatic hypotension, the patient reports a reduction in dizziness episodes. Her blood pressure readings have stabilized to some extent, now averaging 110/75 mmHg upon standing, suggesting a partial improvement in her orthostatic symptoms. However, the healthcare team remains vigilant, recognizing that the patient's cardiovascular status requires continuous monitoring to avoid further complications.

Despite these improvements, new complications have emerged, particularly concerning her renal health. A follow-up lab test indicates a further increase in her urine albumin-to-creatinine ratio, now at 400 mg/g. This suggests progressive renal impairment, which could be exacerbated by the SGLT2 inhibitor, a known factor in altering renal hemodynamics. The patient's serum creatinine level has also risen slightly from 1.5 mg/dL to 1.7 mg/dL, warranting a thorough reassessment of her medication regimen and potential nephrotoxic interactions.

The patient's journey now hinges on an intricate balance of optimizing her glycemic control while safeguarding renal function. The care team must employ clinical reasoning to weigh the benefits and risks of continuing the SGLT2 inhibitor, possibly considering alternative diabetic medications or adjusting dosages. Additionally, further investigation into her renal status through a nephrology consult and imaging studies may provide critical insights to guide future interventions, ensuring a holistic approach to her long-term care.

Section 5

Two weeks after the nephrology consult and subsequent adjustments in her medication regimen, the patient exhibits new diagnostic results that suggest a shift in her clinical status. A renal ultrasound reveals mild renal parenchymal changes consistent with early chronic kidney disease, raising concerns about ongoing renal impairment. In response to these findings, the SGLT2 inhibitor was discontinued, and the patient was transitioned to a GLP-1 receptor agonist, which offers the dual benefit of glycemic control without the same degree of renal hemodynamic impact. Additionally, her antihypertensive therapy was modified to include an ACE inhibitor, aiming to provide renal protection through its vasodilatory effects on the efferent arterioles.

The care team notes a positive response to these interventions, as evidenced by a slight improvement in renal function markers. The patient's serum creatinine has stabilized at 1.6 mg/dL, and her urine albumin-to-creatinine ratio has decreased to 350 mg/g, indicating a slowing of renal deterioration. However, the patient's blood pressure has become more variable, with occasional readings of 130/85 mmHg, necessitating close monitoring to strike an optimal balance between cardiovascular and renal health.

These diagnostic results and subsequent interventions underscore the complexity of managing a patient with concurrent cardiovascular and renal issues. The healthcare team must continue to employ clinical reasoning to adjust treatment plans dynamically, ensuring that both glycemic control and renal preservation are prioritized. This approach demands ongoing collaboration with nephrology and endocrinology specialists to refine the patient's care strategy, aiming for stabilization of her condition while minimizing the risk of further complications. As the patient's journey progresses, the team remains vigilant, anticipating potential challenges and opportunities for further intervention.